Table 2.
SC Lipid Model Composition | Porous Substrate |
Characterisation Techniques | Model Compounds | Main Outcomes | Ref. |
---|---|---|---|---|---|
Airbrush approaches | |||||
Cer:Chol:FFA (1:1:1 mol ratio) Cer = [EOS]:[NS]:[NP24]: [AS]:[NP16]:[AP] (15:51:16:4:9:5 molar ratio) FFA = PA:SA:AA:BA:TA:LA:CA (1.3:3.3:6.7:41.7:5.4:36.8:4.7 molar ratio) |
Polycarbonate 50 nm filter | SWAXS and CryoEM | n.a. |
|
[58] |
Diffusion studies | PABA, ethyl-PABA, and butyl-PABA |
|
[30] | ||
Cer:Chol:FFA (1:1:1 molar ratio) Cer = [EOS]:[NS]:[NP24]: [AS]:[NP16]:[AP] (15:51:16:4:9:5 molar ratio) FFA = PA:SA:AA:BA:TA:LA:CA (1.8:4:7.7:42.6:5.2:34.7:4.1 molar ratio) |
Polycarbonate 50 nm filter | Different airbrush methods, SAXS, and diffusion studies | Benzoic acid |
|
[79] |
Cer:Chol:FFA:ChSO4 (Variable ratio) Cer = [EOS]:[NS]:[NP24]: [AS]:[NP16]:[AP] (15:51:16:4:9:5 molar ratio) FFA = PA:SA:AA:BA:TA:LA:CA (1.8:4:7.7:42.6:5.2:34.7:4.1 mol%) |
Polycarbonate 50 nm filter | FTIR, SAXS, and permeability studies | Benzoic acid |
|
[171] |
Cer:Chol:FFA (1:1:1 molar ratio) Cer = [EOS]:[NS]:[NP]:[AP] (15:51:16:4:9:5 molar ratio) FFA = PA:SA:AA:BA:TA:LA:CA or MyA:PA:SA:AA:BA (Variable ratio) |
Polycarbonate 50 nm filter | SAXS, EM, and permeation studies | Benzoic acid |
|
[172] |
Cer[AP]:Chol:PA:ChS (55:25:15:5 wt%) |
Polycarbonate 50 nm filter | SAXS, polarisation, confocal and ESEM microscopies, Raman imaging, FTIR, and diffusion studies | Urea |
|
[173] |
Cer:Chol:FFA (1:1:1 molar ratio) Cer = [EOS]:[NS]:[NP24]:[NP16] (16:56:18:10 mol%) |
Polycarbonate 50 nm filter | FTIR and interaction studies | γ-undecalactone, DDA, and diethyl 1,4-cyclohexanedicarboxylate |
|
[174] |
Cer[NS]:Chol:PA (1:1:1 molar ratio) |
Polycarbonate 50 nm filter | Laurdan fluorescence, SEM, Raman scattering, and permeability studies | Benzoic acid and CAF |
|
[175] |
Cer:Chol:FFA (1:1:1 molar ratio) pigCer or synCer = [EOS]:[EOP]:[NS]:[NP24]: [AS]:[NP16]:[AP] (Variable ratio) FFA = PA:SA:AA:BA:TA:LA:CA (1.8:4:7.7:42.6:5.2:34.7:4.1 mol%) |
Polycarbonate 50 nm filter | SAXS, FTIR, and permeation studies | HC |
|
[164] |
Cer:Chol:FFA (1:1:1 molar ratio) Cer = [EOS]:[NS]:[NP24]: [AS]:[NP16]:[AP] (15:51:16:4:9:5 molar ratio) FFA = PA:SA:AA:BA:TA:LA:CA (1.8:4:7.7:42.6:5.2:34.7:4.1 mol%) |
Polycarbonate 50 nm filter | SAXS, FTIR, TEWL, and permeation studies | HC |
|
[176] |
aCer:Chol:LA:ChS (1:1:1 molar ratio + 5 wt%) |
Polycarbonate 15 nm filter | IR, SWAXS, and permeation studies | TH and IND |
|
[177] |
Cer:Chol:FFA (1:1:1 molar ratio) Cer = [NS] or [NS]:[NP24]:[AS]:[NP16]: [AP] (60:19:5:11:6 mol%) FFA = PA:SA:AA:BA:LA(1.8:4:7.6:47.8:38.9 mol%) |
Polycarbonate 50 nm filter | FTIR, XRD, and permeability studies | ethyl-PABA |
|
[178] |
Cer:Chol:SA:ChS (1:1:1 molar ratio + 5 wt%) Cer = [NP]:[AP] (Variable ratio) |
Polycarbonate 15 nm filter | IR, EI, EM, and permeation studies | TH and IND |
|
[179] |
Cer:Chol:FFA (1:1:1 molar ratio) Cer = [EOS]:[NS], [EOS]:[AS], [EOS]:[NP] or [EOS]:[AP] (40:60 mol%) FFA = PA:SA:AA:BA:LA (1.8:4:7.6:47.8:38.8 mol%) |
Polycarbonate 50 nm filter | FTIR, X-ray, and permeability studies | ethyl-PABA |
|
[169] |
Cer:Chol:FFA (1:1:1 molar ratio) Cer = [EOS]:[NS]:[NS24]: [NS16]:[NP]:[AS24]: [AS16]:[AP24] (Variable ratio) FFA = PA:SA:AA:BA:LA (Variable ratio) |
Polycarbonate 50 nm filter | FTIR, SWAXS, permeability studies, and TEWL | ethyl-PABA |
|
[180] |
hCer:Chol:FFA:ChS (1:1:1 molar ratio + 5 wt%) FFA = PA:SA:AA:BA:LA (1.8:4:7.6:47.8:38.8 mol%) Cer[NS]:Cer[EOS]:Chol: LA:ChS (Variable ratio) |
Polycarbonate 15 nm filter | WAXS, FTIR, TEWL, electrical impedance, and permeation studies | TH and IND |
|
[181] |
aCer[NS]:Chol:LA:ChS (1:1:1 molar ratio + 5 wt%) |
Polycarbonate 15 nm filter | XRD, IR spectroscopy, permeability studies, water loss, and electrical impedance | TH and IND |
|
[36] |
Cer:Chol:LA (1:1:1 molar ratio) Cer = [EOS]:[NS24] or [EOS:NS16] (Variable ratio) |
Polycarbonate 50 nm filter | FTIR, SAXS, and permeation studies | ethyl-PABA |
|
[182] |
Cer:Chol:FFA+ChS (1:1:1 molar ratio + 5 wt%) Cer = [NS], R-/S-[AS], [NdS], R-/S-[AdS], [NP] or R-/S-[AP] |
Polycarbonate 15 nm filters | XRD, FTIR, and permeability studies | TH and IND |
|
[37] |
Cer:Chol:FFA (1:1:1 molar ratio) Cer = [EOS]:[NS] (10–90:90–10 mol%) FFA = PA:SA:AA:BA:LA (1.8:4:7.6:47.8:38.8 mol%) |
Polycarbonate 50 nm filters | SAXS, FTIR, permeation studies, and TEWL | ethyl-PABA |
|
[183] |
Cer:Chol:FFA:ChS (1:1:1 molar ratio + 5 wt%) Cer = [EOP]:[EOdS]:[EOS]: [AP]:[AS]:[NP]:[NS]: [NdS]:[AdS] (Variable ratio) FFA = BA:LA:AA:SA:PA (47.1:41.4:6.9:3.3:1.3 mol%) |
Polycarbonate 15 nm filter | XRD, FTIR, electrical impedance, and permeability studies | TH and IND |
|
[184] |
|
[185] | ||||
Cer[NS]:Chol:FFA:ChS (Variable ratio) FFA = PA:SA:AA:BA:LA (1.8:3.9:7.5:47.8:39 mol%) |
Polycarbonate 15 nm filters | H-NMR, SAXS, WAXS, zeta potential, and permeability studies | TH and IND |
|
[186] |
Cer[NS]:Chol:PA (1:1:1 molar ratio) |
Polycarbonate 50 nm filters | SEM, DLS, and permeation studies | CAF |
|
[187] |
Skin-PAMPATM approaches | |||||
Certramides:Chol:SA (0 to 1:1:1 molar ratio) |
Multiscreen-IP 450 nm pores | Permeability studies | CIP, NFD, and VER |
|
[80] |
Certramides:Chol:SA: Si oil |
StirwellTM PAMPA | Permeability studies | APAP, DCF, FUR, NAP, PEF, TH, and VER |
|
[188] |
PVPA-based approaches | |||||
E80:BSCCer:Chol:PA:ChS (77:23:0:0:0 or 50:27.5:12.5:7.5:2.5 wt%) |
Mixed cellulose ester 650 nm filters | Permeation studies | Flu, IBP, IND, SAL, FITC-dextran, and CAL |
|
[189] |
E80:BSCCer:Chol:PA:ChS (50:27.5:12.5:2.5:7.5 wt%) |
Mixed cellulose ester 650 nm filters | Permeation and stability studies | Liposomal formulations of DCF |
|
[190] |
E80:BSCCer:Chol:PA:ChS (77:23:0:0:0 or 50:27.5:12.5:7.5:2.5 wt%) |
Mixed cellulose ester 650 nm filters | Stability and permeation studies | CAF, ACV, CPL, and CAL (liposomal formulation and/or aqueous solution) |
|
[191] |
Diffusion studies | CAF, DCF, CAP and CAL |
|
[192] | ||
EPC/SPC:BSCCer:Chol:PA:ChS (25–80:41–11:18–5: 3.75–1:11.25–3 wt%) |
Nylon 450 nm filters | Menthol enhancer permeation studies, comparison with porcine ear skin and ATR-FTIR | FCA, PF, ALB, THC, and THP |
|
[193] |
EPC:Chol (77:23 wt%) |
Nylon 450 nm filters | SEM, electrical resistance, ATR-FTIR, and permeation studies | FCA, PF, ALB, THC, and THP |
|
[194] |
Cer:EPC:Chol:SA:ChS (50:25:12.5:10:2.5 wt%) |
Polycarbonate 400 nm filters | SEM, electrical resistance permeation, and stability studies | CAL, CAF, CSP, DCF, MTX, and NAP |
|
[195] |
Stability studies and permeability studies | CAL |
|
[196] |
aCer—analog ceramides; AA—arachidic acid; ALB—albiflorin; APAP—acetaminophen; ATR-FTIR—attenuated total teflection Fourier-transform infrared; BA—behenic acid; BSC—bovine spinal cord; CA—cerotic acid; CAF—caffeine; CAL—calcein; CAP—chloramphenicol; Cer—ceramide; Cer[AdS]—α-hydroxy fatty acid/dihydrosphingosine base ceramide; Cer[AP]—α-hydroxy fatty acid/phytosphingosine base ceramide; Cer[EOdS]—ω-hydroxy fatty acid/dihydro-sphingosine base ceramide; Cer[EOS]—ester-linked ω-hydroxy fatty acid/sphingosine base ceramide; Cer[NdS]—non-hydroxy fatty acid/dihydrosphingosine base ceramide; Cer[NP]—non-hydroxy fatty acid/phytosphingosine base ceramide; Cer[NS]—non-hydroxy fatty acid/sphingosine base ceramide; Chol—cholesterol; ChS—cholesteryl sulfate; CIP—ciprofloxacin; CSP—cyclosporine; DCF—diclofenac; DDA—dodecyl acetate; DLS—dynamic light scattering; E-80—egg phospholipid lipoid E-80; EM—electron microscopy; EPC—egg phosphatidylcholine; ESEM—environmental scanning electron microscopy; FCA—ferulic acid; FFA—free fatty acid; Flu—flufenamic acid; FTIR—Fourier-transform infrared; FUR—furosemide; HC—hydrocortisone; hCer—human isolated ceramide; IBP—ibuprofen; IND—indomethacin; IR—infrared; LA—lignoceric acid; MTX—methotrexate; NAP—naproxen; NFD—nifedipine; PA—palmitic acid; PABA—p-aminobenzoic acid; PAMPA—parallel artificial membrane permeability assay; PEF—pefloxacin; PF—paeoniflorin; PVPA—phospholipid vesicle-based permeation assay; pigCer—pig isolated ceramide; SA—stearic acid; SAL—salicylic acid; SAXS—small-angle X-ray scattering; synCer—synthetic ceramide; SEM—scanning electron microscopy; SPC—soybean phosphatidylcholine; SWAXS—small- and wide-angle X-ray scattering; TA—tricosylic acid; TEWL—transepidermal water loss; TH—theophylline; THC—tetrahydrocolumbamine; THP—tetrahydropalmatine; WAXS—wide-angle X-ray scattering; VER—verapamil; XRPD—X-ray powder diffraction.